Aurobindo Receives FDA Approval for the line of OC tablets Aurovela™
East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for Aurovela™ line of OC tablets. The Division of Bioequivalence has determined Aurobindo Pharma Limited’s Aurovela™ to be bioequivalent and, therefore, therapeutically equivalent to Loestrin® line of oral contraceptive products. Please see table below for each of […]
Aurobindo Receives FDA Approval for the line of OC tablets Aurovela™ Read More »